PapersFlow Research Brief

Health Sciences · Medicine

Sirtuins and Resveratrol in Medicine
Research Guide

What is Sirtuins and Resveratrol in Medicine?

Sirtuins and resveratrol in medicine refers to the study of sirtuin enzymes (SIRT1-7), which regulate metabolism, aging, and cellular homeostasis, and the compound resveratrol, which activates these enzymes to influence longevity and age-related diseases.

The field encompasses 32,434 papers on sirtuins' roles in metabolism, aging, mitochondria, NAD+, calorie restriction, oxidative stress, and cellular homeostasis. Resveratrol activates SIRT1, improving mitochondrial function and protecting against metabolic disease as shown in mouse models. Key mechanisms involve SIRT1 deacetylation of targets like PGC-1α and FOXO transcription factors under stress or nutrient control.

Topic Hierarchy

100%
graph TD D["Health Sciences"] F["Medicine"] S["Geriatrics and Gerontology"] T["Sirtuins and Resveratrol in Medicine"] D --> F F --> S S --> T style T fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan
32.4K
Papers
N/A
5yr Growth
1.0M
Total Citations

Research Sub-Topics

Why It Matters

Resveratrol activates SIRT1 and PGC-1α to improve mitochondrial function and protect against metabolic disease in vivo (Lagouge et al., 2006, "Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α"). In mice on a high-calorie diet, resveratrol improved health and survival, mimicking calorie restriction benefits (Baur et al., 2006, "Resveratrol improves health and survival of mice on a high-calorie diet"). Therapeutic potential includes treatment of age-related diseases, with in vivo evidence for resveratrol's effects on longevity pathways (Baur and Sinclair, 2006, "Therapeutic potential of resveratrol: the in vivo evidence"). Sirtuin activators extended yeast lifespan (Howitz et al., 2003, "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan"), supporting applications in geriatrics.

Reading Guide

Where to Start

"Therapeutic potential of resveratrol: the in vivo evidence" by Baur and Sinclair (2006) provides an accessible entry point with a focused review of resveratrol's effects on sirtuins and evidence for medical applications.

Key Papers Explained

Imai et al. (2000, "Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase") established sirtuins as NAD-dependent deacetylases linking them to longevity. Howitz et al. (2003, "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan") identified resveratrol as a sirtuin activator in yeast. Lagouge et al. (2006, "Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α") and Baur et al. (2006, "Resveratrol improves health and survival of mice on a high-calorie diet") extended these to mammalian mitochondrial and survival effects via SIRT1. Rodgers et al. (2005, "Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1") and Brunet et al. (2004, "Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase") detailed SIRT1's regulatory complexes and stress responses.

Paper Timeline

100%
graph LR P0["Transcriptional silencing and lo...
2000 · 3.4K cites"] P1["Small molecule activators of sir...
2003 · 3.7K cites"] P2["Resveratrol improves health and ...
2006 · 4.2K cites"] P3["Resveratrol Improves Mitochondri...
2006 · 3.9K cites"] P4["Therapeutic potential of resvera...
2006 · 3.8K cites"] P5["Dose translation from animal to ...
2007 · 6.1K cites"] P6["Self-eating and self-killing: cr...
2007 · 3.6K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P5 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Current work builds on SIRT1's role in nutrient sensing via AMPK and NAD+ (Cantó et al., 2009, "AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity"), with focus on translating mouse survival benefits (Baur et al., 2006) to human dosing (Reagan-Shaw et al., 2007). No recent preprints available.

Papers at a Glance

Frequently Asked Questions

What role does resveratrol play in activating sirtuins?

Resveratrol activates SIRT1, which deacetylates PGC-1α to improve mitochondrial function and protect against metabolic disease (Lagouge et al., 2006, "Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α"). It also enhances health and survival in mice on high-calorie diets (Baur et al., 2006, "Resveratrol improves health and survival of mice on a high-calorie diet"). These effects mimic calorie restriction through sirtuin pathways.

How do sirtuins regulate aging and longevity?

Sirtuins like Sir2/SIRT1 are NAD-dependent histone deacetylases that promote transcriptional silencing and extend lifespan in yeast (Imai et al., 2000, "Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase"). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan (Howitz et al., 2003, "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan"). In mammals, SIRT1 modulates stress responses via FOXO factors (Brunet et al., 2004, "Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase")."

What is the connection between sirtuins, NAD+, and AMPK?

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity (Cantó et al., 2009, "AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity"). SIRT1 forms a complex with PGC-1α for nutrient control of glucose homeostasis (Rodgers et al., 2005, "Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1"). These interactions link energy sensing to sirtuin function.

How is resveratrol dosage translated from animals to humans?

Dose translation from animal to human studies uses allometric scaling based on body surface area, not weight alone (Reagan-Shaw et al., 2007, "Dose translation from animal to human studies revisited"). This method ensures appropriate dosing for preclinical to clinical studies involving compounds like resveratrol. Misunderstandings in scaling can affect trial outcomes.

What are the therapeutic applications of resveratrol?

Resveratrol shows in vivo evidence for therapeutic potential in age-related diseases through sirtuin activation (Baur and Sinclair, 2006, "Therapeutic potential of resveratrol: the in vivo evidence"). It improves survival in high-calorie diet models and mitochondrial function (Baur et al., 2006; Lagouge et al., 2006). Applications target metabolism and longevity pathways.

Open Research Questions

  • ? How does SIRT1 precisely integrate signals from AMPK, NAD+ levels, and oxidative stress to regulate mitochondrial biogenesis in aging tissues?
  • ? What are the specific downstream targets of SIRT1 deacetylation beyond PGC-1α and FOXO that mediate resveratrol's effects on lifespan extension?
  • ? Why do sirtuin activators like resveratrol extend lifespan in yeast and mice but show variable efficacy in human clinical trials?
  • ? How do interactions between sirtuins and autophagy-apoptosis pathways influence cellular homeostasis under calorie restriction?
  • ? What mechanisms control the tissue-specific expression and activity of SIRT1-7 in response to metabolic stress?

Research Sirtuins and Resveratrol in Medicine with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Sirtuins and Resveratrol in Medicine with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers